These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
474 related articles for article (PubMed ID: 20675065)
1. Usefulness of interim FDG-PET after induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck receiving sequential induction chemotherapy followed by concurrent chemoradiotherapy. Yoon DH; Cho Y; Kim SY; Nam SY; Choi SH; Roh JL; Lee SW; Song SY; Lee JH; Kim JS; Cho KJ; Kim SB Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):118-25. PubMed ID: 20675065 [TBL] [Abstract][Full Text] [Related]
2. The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer. Kim KR; Shim HJ; Hwang JE; Cho SH; Chung IJ; Park KS; Kang SR; Kwon SY; Chung WK; Bae WK Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):170-178. PubMed ID: 28940101 [TBL] [Abstract][Full Text] [Related]
3. The Role of 18-Fluoro-2-Deoxy-Glucose Positron Emission Tomography/Computed Tomography as Response and Prognosis Predictive Factor of Concurrent Chemoradiotherapy after Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Prospective Study. Šedienė S; Kulakienė I; Rudžianskas V; Ambrazienė R Medicina (Kaunas); 2018 May; 54(2):. PubMed ID: 30344262 [No Abstract] [Full Text] [Related]
4. Use of Rudžianskas V; Korobeinikova E; Rudžianskienė M; Jaselskė E; Adlienė D; Šedienė S; Kulakienė I; Padervinskis E; Jurkienė N; Juozaitytė E Medicina (Kaunas); 2018 Dec; 54(6):. PubMed ID: 30544718 [No Abstract] [Full Text] [Related]
5. The predictive value of Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma. Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer. Oh D; Lee JE; Huh SJ; Park W; Nam H; Choi JY; Kim BT Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):549-54. PubMed ID: 24074928 [TBL] [Abstract][Full Text] [Related]
8. Early metabolic 18F-FDG PET/CT response of locally advanced squamous-cell carcinoma of head and neck to induction chemotherapy: A prospective pilot study. Nicolau UR; de Jesus VHF; Lima ENP; Alves MS; de Oliveira TB; Andrade LB; Silva VS; Bes PC; de Paiva TF; Calsavara VF; Guimarães APG; Cezana L; Barbosa PNVP; Porto GCLM; Pellizzon ACA; de Carvalho GB; Kowalski LP PLoS One; 2018; 13(8):e0200823. PubMed ID: 30114190 [TBL] [Abstract][Full Text] [Related]
9. A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer. Hitt R; Grau JJ; López-Pousa A; Berrocal A; García-Girón C; Irigoyen A; Sastre J; Martínez-Trufero J; Brandariz Castelo JA; Verger E; Cruz-Hernández JJ; Ann Oncol; 2014 Jan; 25(1):216-25. PubMed ID: 24256848 [TBL] [Abstract][Full Text] [Related]
10. Single-cycle induction chemotherapy followed by chemoradiotherapy or surgery in patients with head and neck cancer: what are the best predictors of remission and prognosis? Semrau S; Haderlein M; Schmidt D; Lell M; Wolf W; Waldfahrer F; Uder M; Iro H; Kuwert T; Fietkau R Cancer; 2015 Apr; 121(8):1214-22. PubMed ID: 25537381 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study. Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925 [TBL] [Abstract][Full Text] [Related]
12. Early prediction of survival following induction chemotherapy with DCF (docetaxel, cisplatin, 5-fluorouracil) using FDG PET/CT imaging in patients with locally advanced head and neck squamous cell carcinoma. Abgral R; Le Roux PY; Keromnes N; Rousset J; Valette G; Gouders D; Leleu C; Mollon D; Nowak E; Querellou S; Salaün PY Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1839-47. PubMed ID: 22895863 [TBL] [Abstract][Full Text] [Related]
13. Clinical usefulness of [18F] fluoro-2-deoxy-D-glucose uptake in 178 head-and-neck cancer patients with nodal metastasis treated with definitive chemoradiotherapy: consideration of its prognostic value and ability to provide guidance for optimal selection of patients for planned neck dissection. Inokuchi H; Kodaira T; Tachibana H; Nakamura T; Tomita N; Nakahara R; Takada A; Mizoguchi N; Tamaki T; Fuwa N Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):747-55. PubMed ID: 20434274 [TBL] [Abstract][Full Text] [Related]
14. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma. Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422 [TBL] [Abstract][Full Text] [Related]
15. Does response to induction chemotherapy predict survival for locally advanced non-small-cell lung cancer? Secondary analysis of RTOG 8804/8808. McAleer MF; Moughan J; Byhardt RW; Cox JD; Sause WT; Komaki R Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):802-8. PubMed ID: 19540055 [TBL] [Abstract][Full Text] [Related]
16. Interim FDG PET/CT for predicting the outcome in patients with head and neck cancer. Chen SW; Hsieh TC; Yen KY; Yang SN; Wang YC; Chien CR; Liang JA; Kao CH Laryngoscope; 2014 Dec; 124(12):2732-8. PubMed ID: 25042474 [TBL] [Abstract][Full Text] [Related]
17. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers. Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135 [TBL] [Abstract][Full Text] [Related]
18. A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx. Huang PW; Lin CY; Hsieh CH; Hsu CL; Fan KH; Huang SF; Liao CT; Ng SK; Yen TC; Chang JT; Wang HM Biomed J; 2018 Apr; 41(2):129-136. PubMed ID: 29866601 [TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer. McCollum AD; Burrell SC; Haddad RI; Norris CM; Tishler RB; Case MA; Posner MR; Van den Abbeele AD Head Neck; 2004 Oct; 26(10):890-6. PubMed ID: 15390197 [TBL] [Abstract][Full Text] [Related]
20. Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinoma. Slevin F; Subesinghe M; Ramasamy S; Sen M; Scarsbrook AF; Prestwich RJ Br J Radiol; 2015 Aug; 88(1052):20140592. PubMed ID: 26081447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]